Having trouble accessing articles? Reset your cache.

Belgian family raises $2.1M for Zolgensma after Novartis denies compassion use request

A Belgian child is set to receive gene therapy Zolgensma after her parents raised over $2 million for the spinal muscular atrophy treatment. The family appealed for donations after Novartis refused to provide the therapy, which has not been approved in Europe, on a compassionate-use basis.

The De Meyer family have raised €1.8 million ($2 million) through a text messaging campaign and €100,000 through a

Read the full 657 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers